SpaceX shares fell below the $135 IPO price for the first time, raising concerns among traders about future performance.

NextCure's merger with Avere Therapeutics could position NXTC for growth in the public markets.

General Fusion is on track to become the first publicly traded fusion company, a significant milestone for the energy se…

Lime's $1.7 billion IPO highlights a resurgence in market enthusiasm for new public offerings.

OpenPayd's SPAC merger with Titan Acquisition Corp. signals a promising future for fintech. Here's what investors need t…

Onex Partners' acquisition of AirSprint signals growth potential in private aviation and highlights market consolidation…

Cboe's new prediction markets could reshape trading dynamics and offer fresh opportunities for traders.

The merger of Boundless Bio and Serapha Bio, backed by a $230M placement, signals growth potential in biotech.

SpaceX launches senior unsecured notes offering post-IPO while disclosing massive cash reserves. KeyBanc initiates cover…

California anticipates a tax windfall from tech IPOs, but uncertainties loom over revenue sustainability.

Copley Acquisition Corp's SPAC merger with Ignite Proteomics could reshape the oncology diagnostics landscape.

Copley Acquisition Corp's merger with Ignite Proteomics could reshape precision oncology investment opportunities.